CPC Main Group
A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system
9 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61P 1/02 Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 1/04 for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/06 Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A61P 1/08 for nausea, cinetosis or vertigo; Antiemetics
- A61P 1/10 Laxatives
- A61P 1/12 Antidiarrhoeals
- A61P 1/14 Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A61P 1/16 for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 1/18 for pancreatic disorders, e.g. pancreatic enzymes
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513